Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,134 JPY | +0.78% | -0.10% | +1.97% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Sales 2024 | 4,264B 27.14B | Sales 2025 * | 4,097B 26.08B | Capitalization | 6,436B 40.97B |
---|---|---|---|---|---|
Net income 2024 | 144B 917M | Net income 2025 * | 136B 864M | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24B | Net Debt 2025 * | 4,204B 26.76B | EV / Sales 2025 * | 2.6 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
45.5
x | Employees | 49,095 |
Yield 2024 * |
4.58% | Yield 2025 * |
4.65% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +0.78% | ||
1 week | -0.10% | ||
Current month | -0.46% | ||
1 month | +0.29% | ||
3 months | -7.76% | ||
6 months | -1.64% | ||
Current year | +1.97% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 19 M€ | +9.53% | ||
5.00% | 288 M€ | +25.23% | ||
3.80% | 1,531 M€ | +21.79% | ||
3.43% | 240 M€ | +17.47% | ||
3.26% | 60 M€ | +23.21% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 4,134 | +0.78% | 2 722 100 |
24-05-22 | 4,102 | -0.75% | 2,557,900 |
24-05-21 | 4,133 | -0.77% | 2,527,700 |
24-05-20 | 4,165 | +0.85% | 2,987,200 |
24-05-17 | 4,130 | -0.19% | 3,239,600 |
Delayed Quote Japan Exchange, May 23, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 41.12B | |
+38.76% | 723B | |
+33.89% | 595B | |
-3.17% | 369B | |
+20.60% | 332B | |
+2.88% | 282B | |
+17.30% | 244B | |
+9.40% | 208B | |
-4.74% | 205B | |
+0.61% | 168B |
- Stock Market
- Equities
- 4502 Stock